Distribution and density of tertiary lymphoid structures predict clinical outcome in intrahepatic cholangiocarcinomaGuangyu Ding, Jiaqiang Ma, Jing‐Ping Yun et al.|Journal of Hepatology|2021Cited by 245
Suppression of ACADM-Mediated Fatty Acid Oxidation Promotes Hepatocellular Carcinoma via Aberrant CAV1/SREBP1 SignalingP. Y. Angel, Judy Wai Ping Yam, Cherlie Lot Sum Yeung et al.|Cancer Research|2021Cited by 127
Caspase-3–Induced Activation of SREBP2 Drives Drug Resistance via Promotion of Cholesterol Biosynthesis in Hepatocellular CarcinomaEtienne Ho Kit Mok, Terence K. Lee, Carmen Leung et al.|Cancer Research|2022Cited by 106
Increased expression of hepatocyte nuclear factor 4 alpha transcribed by promoter 2 indicates a poor prognosis in hepatocellular carcinomaShaohang Cai, Jing‐Ping Yun, Shi-Xun Lu et al.|Therapeutic Advances in Gastroenterology|2017Cited by 60
TPI1‐reduced extracellular vesicles mediated by Rab20 downregulation promotes aerobic glycolysis to drive hepatocarcinogenesisBonnie Hei Man Liu, Judy Wai Ping Yam, Angel Po Yee et al.|Journal of Extracellular Vesicles|2021Cited by 59